BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22552250)

  • 1. Ustekinumab for peristomal pyoderma gangrenosum.
    Fahmy M; Ramamoorthy S; Hata T; Sandborn WJ
    Am J Gastroenterol; 2012 May; 107(5):794-5. PubMed ID: 22552250
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment with infliximab of peristomal pyoderma gangrenosum in ulcerative colitis].
    Krag AA; Gjersøe P
    Ugeskr Laeger; 2005 May; 167(18):1968-9. PubMed ID: 15929274
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycophenolate mofetil is an effective treatment for peristomal pyoderma gangrenosum.
    Daniels NH; Callen JP
    Arch Dermatol; 2004 Dec; 140(12):1427-9. PubMed ID: 15611417
    [No Abstract]   [Full Text] [Related]  

  • 4. [Infliximab treatment of peristomal pyoderma gangrenosum in ulcerative colitis].
    Nybaek H; Jemec GB
    Ugeskr Laeger; 2005 Aug; 167(32):2920-1. PubMed ID: 16109221
    [No Abstract]   [Full Text] [Related]  

  • 5. Beclometasone inhaler used to treat pyoderma gangrenosum.
    Chriba M; Skellett AM; Levell NJ
    Clin Exp Dermatol; 2010 Apr; 35(3):337-8. PubMed ID: 20500206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adalimumab treatment for peristomal pyoderma gangrenosum associated with Crohn's disease.
    Alkhouri N; Hupertz V; Mahajan L
    Inflamm Bowel Dis; 2009 Jun; 15(6):803-6. PubMed ID: 18942748
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of peristomal pyoderma gangrenosum.
    Kiran RP; O'Brien-Ermlich B; Achkar JP; Fazio VW; Delaney CP
    Dis Colon Rectum; 2005 Jul; 48(7):1397-403. PubMed ID: 15868233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Management of Peristomal Pyoderma Gangrenosum in IBD.
    O'Brien SJ; Ellis CT
    Dis Colon Rectum; 2020 Jul; 63(7):881-884. PubMed ID: 32496328
    [No Abstract]   [Full Text] [Related]  

  • 9. Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease.
    Funayama Y; Kumagai E; Takahashi K; Fukushima K; Sasaki I
    Dis Colon Rectum; 2009 Feb; 52(2):311-4. PubMed ID: 19279428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of peristomal pyoderma gangrenosum with topical crushed dapsone.
    Handler MZ; Hamilton H; Aires D
    J Drugs Dermatol; 2011 Sep; 10(9):1059-61. PubMed ID: 22052278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A debilitating cause of parastomal pain in a patient with Crohn disease.
    Benn NJ; Halasy M
    JAAPA; 2014 Sep; 27(9):15-6. PubMed ID: 25148439
    [No Abstract]   [Full Text] [Related]  

  • 12. Resolution of severe peristomal pyoderma gangrenosum with infliximab in a child with Crohn disease.
    Batres LA; Mamula P; Baldassano RN
    J Pediatr Gastroenterol Nutr; 2002 May; 34(5):558-60. PubMed ID: 12050585
    [No Abstract]   [Full Text] [Related]  

  • 13. [Peristomal pyoderma gangrenosum after colectomy for Crohn disease. Successful medical treatment].
    Goudet P; Pillon D; Bensa F; Collet E; Cougard P; Viard H
    Ann Chir; 1992; 46(6):525-9. PubMed ID: 1444154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases.
    Khurrum Baig M; Marquez H; Nogueras JJ; Weiss EG; Wexner SD
    Colorectal Dis; 2004 Jul; 6(4):250-3. PubMed ID: 15206967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab for peristomal pyoderma gangrenosum.
    Mimouni D; Anhalt GJ; Kouba DJ; Nousari HC
    Br J Dermatol; 2003 Apr; 148(4):813-6. PubMed ID: 12752145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peristomal pyoderma gangrenosum and inflammatory bowel disease.
    Cairns BA; Herbst CA; Sartor BR; Briggaman RA; Koruda MJ
    Arch Surg; 1994 Jul; 129(7):769-72. PubMed ID: 7912923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyoderma gangrenosum and tumor necrosis factor α agents.
    Rallis E; Koumantaki-Mathioudaki E; Tsiatoura A; Stavropoulos P; Katsambas A
    Cutis; 2013 Oct; 92(4):E1-2. PubMed ID: 24195097
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of etanercept in the treatment of peristomal pyoderma gangrenosum.
    Kim FS; Pandya AG
    Clin Exp Dermatol; 2012 Jun; 37(4):442-3. PubMed ID: 22582915
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.